Stephen L. Huhn

Insider Reports History

Entity
Individual
Location
10578 Science Center Drive, Suite 200, San Diego, CA
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen L. Huhn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Contineum Therapeutics, Inc. CMO & Sr VP, Clinical Dev. Class A Common Stock 12.8K $218K $17.05 Aug 13, 2024 Direct
Contineum Therapeutics, Inc. CMO & Sr VP, Clinical Dev. Stock Option (right to buy) 161K Aug 13, 2024 Direct

Insider Reports Filed by Stephen L. Huhn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTNM Contineum Therapeutics, Inc. Aug 13, 2024 2 $12.9K 4 Aug 14, 2024 CMO & Sr VP, Clinical Dev.
CTNM Contineum Therapeutics, Inc. May 24, 2024 1 $0 4 May 29, 2024 CMO & Sr VP, Clinical Dev.
CTNM Contineum Therapeutics, Inc. Apr 4, 2024 0 $0 3 Apr 4, 2024 CMO & Sr VP, Clinical Dev.